Israel Englander’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Israel Englander’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,637	Closed	-$30K	–	4279
2015 Q1	$30K	Sell	7,637 -44,783	-85%	-$201K	﹤0.01%	3493
2014 Q4	$725K	Buy	52,420 +7,298	+16%	+$104K	﹤0.01%	2728
2014 Q3	$560K	Buy	45,122 +1,097	+2%	+$15.1K	﹤0.01%	2677
2014 Q2	$803K	Sell	44,025 -15,507	-26%	-$265K	﹤0.01%	2320
2014 Q1	$1.29M	Buy	59,532 +41,982	+239%	+$1.22M	﹤0.01%	2077
2013 Q4	$621K	Sell	17,550 -375	-2%	-$12.6K	﹤0.01%	2576
2013 Q3	$648K	Buy	+17,925	New	+$816K	﹤0.01%	2382

Other funds holding KBIO

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Israel Englander's KBIO Position: Q2 2015 in Review

Israel Englander sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q2 2015, closing a stake of 7,637 shares — an estimated $30K sold.

Israel Englander first reported a position in KBIO in Q3 2013 and held it in 7 quarters. The position peaked at $1.29M in Q1 2014. 19 funds tracked by Wall St. Rank hold KBIO as of Q2 2015.

Israel Englander reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q2 2015 after selling out during the quarter.
Israel Englander sold 7,637 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q2 2015, an estimated $30K.
Israel Englander first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q3 2013 and held it in 7 quarters.
Israel Englander's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $1.29M in Q1 2014.
19 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q2 2015.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.